+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Post-transplant lymphoproliferative disease in pediatric solid organ transplant recipients



Post-transplant lymphoproliferative disease in pediatric solid organ transplant recipients



Pediatric Hematology and Oncology 30(6): 520-531



Post-transplant lymphoproliferative disease (PTLD) in solid organ transplant (SOT) recipients has become one of the most common forms of lymphoproliferation in childhood and is a serious complication of SOT. More than 90% of cases are of B-cell origin, Epstein Barr virus (EBV) positive and are mostly occurring in the early post-transplant period. Pathologically and clinically it is a heterogenous disease ranging from being responsive to reduced immunosuppression without further intervention to rapidly progressive fulminant PTLD requiring prompt initiation of therapy. Prognosis overall is favorable. Current treatment strategies as well new promising targeted immune-based therapies such as rituximab and EBV-specific cytotoxic T-lymphocytes are being discussed.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 055067608

Download citation: RISBibTeXText

PMID: 23802715

DOI: 10.3109/08880018.2013.798844


Related references

Utility of semiquantitative polymerase chain reaction for Epstein-Barr virus in peripheral blood lymphocytes among pediatric solid-organ transplant recipients with and without post-transplant lymphoproliferative disease. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 39: 432, 1999

The management of Epstein-Barr virus associated post-transplant lymphoproliferative disorders in pediatric solid-organ transplant recipients. Pediatric Transplantation 3(4): 271-281, 1999

Predictive value of cytokine genotyping for the risk of post transplant lymphoproliferative disease in solid organ transplant recipients. Human Immunology 61(Suppl. 2): S138, 2000

CD30 in pediatric post-transplant lymphoproliferative disease after solid organ transplant: characterization of a new therapeutic target. Leukemia and Lymphoma 56(3): 832-833, 2015

Epstein-Barr virus-related post-transplant lymphoproliferative disease in solid organ transplant recipients, 1988-97: a Canadian multi-centre experience. Pediatric Transplantation 5(3): 198-203, 2001

Post transplant lymphoproliferative disease in pediatric solid organ transplant patients: a possible role for [18F]-FDG-PET(/CT) in initial staging and therapy monitoring. European Journal of Radiology 63(3): 427-435, 2007

Mini-BEAM and autologous peripheral blood hematopoietic stem cell transplant for treatment of post transplant lymphoproliferative disorders in solid organ transplant recipients Report of 2 cases. Blood 102(11): 738a, 2003

Association of HLA polymorphisms with post-transplant lymphoproliferative disorder in solid-organ transplant recipients. American Journal of Transplantation 11(4): 817-825, 2011

Cancer risk following post-transplant lymphoproliferative disorders in solid organ transplant recipients. British Journal of Haematology 186(2): 347-351, 2019

Diagnosis of post-transplant lymphoproliferative disorder in solid organ transplant recipients - BCSH and BTS Guidelines. British Journal of Haematology 149(5): 675-692, 2010

Proposed prognostic model for survival in solid organ transplant recipients with post transplant lymphoproliferative disorders. Blood 102(11): 392a, 2003

Post-transplantation lymphoproliferative disorders in bone marrow transplant and solid organ transplant recipients differ. Laboratory Investigation 80(3): 144A, 2000

Management of post-transplant lymphoproliferative disorder in adult solid organ transplant recipients - BCSH and BTS Guidelines. British Journal of Haematology 149(5): 693-705, 2010

Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients. Clinical Microbiology and Infection 20(Suppl. 7): 109-118, 2014

Managing post-transplant lymphoproliferative disorders in solid-organ transplant recipients: a review of immunosuppressant regimens. Drugs 72(12): 1631-1643, 2012